Tenaya Therapeutics is trading at $0.40, up +5.03%, alongside a biotech-sector rally; this offers a sector-level explanation, not a confirmed company catalyst.
- XBI was up 2.09% during the regular session.
- No new company-specific announcement was found for October 20; Tenaya’s latest release listed on its investor site was September 14. The FDA RMAT designation for TN-401 was announced earlier, not on October 20.
- Trading is live; volume and activity data were not provided.